Objectives: To determine the prevalence of the plasmid-mediated quinolone resistance qnrA gene in a selected collection of blood culture isolates of Enterobacteriaceae resistant to both ciprofloxacin and cefotaxime.
Introduction
Plasmid-mediated mechanisms have led to resistance to most major classes of clinically used antimicrobials. The exception appeared to be the quinolones, resistance to which was associated with mutations in the chromosomal genes for type II topoisomerases, the target site for quinolones, and/or changes in expression of efflux pumps and porins, which affect intracellular concentrations. However, the detection of plasmid-mediated quinolone resistance in Klebsiella pneumoniae in 1994 in the United States, 1 has now been followed by sporadic isolations worldwide in differing Enterobacteriaceae including Escherichia coli, Citrobacter freundii and Enterobacter cloacae. [2] [3] [4] [5] [6] [7] The conjugative plasmid associated with the American isolate, pMG252, was unusual in that it encoded multidrug resistance including resistance to quinolones, b-lactams, aminoglycosides, sulphonamides, trimethoprim and chloramphenicol carried in an integron-borne cassette or antibiotic resistance integron.
The gene responsible for plasmid-mediated resistance qnrA (GenBank accession number AY070235) encodes the protein QnrA, a 218 amino acid pentapeptide that binds to subunits of topoisomerase IV, preventing further binding of quinolones. Introduction of plasmid pMG252 into E. coli strains with differing underlying mechanisms of quinolone insusceptibility increased quinolone resistance 4-to 128-fold. 8 Furthermore, plasmid carriage by E. coli facilitated the selection of chromosomal resistance mutations by significantly raising the level at which mutants could be selected. Most qnrA-positive enterobacterial isolates have been associated with the plasmid-mediated AmpC-type b-lactamase (pACBL) FOX-5 or clavulanic acid-inhibited extended-spectrum b-lactamases (ESBLs). As a departmental policy we retain all bacteraemic isolates, therefore we were able to undertake a study to determine the prevalence of qnrA-positive isolates from a collection of Enterobacteriaceae resistant to both ciprofloxacin and cefotaxime isolated from episodes of bacteraemia at the Royal Liverpool University Teaching Hospital (RLUH) over the period January 2003 to May 2005.
Material and methods

Bacteria
A computerized search of blood culture isolates was undertaken for Enterobacteriaceae reported as being both cefotaxime (potential ESBL producers) and ciprofloxacin resistant. A total of 47 non-repetitive isolates were identified and included, 1 C. freundii, 16 E. cloacae, 13 E. coli, 15 K. pneumoniae and 2 Morganella morganii. E. coli J53 (sodium azide-resistant) was used as a conjugation recipient, and E. coli 39R861 (NCTC 50192) and V517 (NCTC 50193) as standards for plasmid analysis.
Susceptibility testing
Disc susceptibility testing was performed according to BSAC guidelines 9 on Iso-Sensitest agar (Oxoid Ltd, Basingstoke, UK). Detection of ESBLs was achieved with a combination of the Mast ESBL set (Mast Laboratories Ltd, Bootle, Merseyside, UK) and cefpirome discs with and without clavulanic acid (Oxoid Ltd). MICs of nalidixic acid and ciprofloxacin were determined by the Etest method (AB Biodisk, Solna, Sweden).
Plasmid analysis and conjugation experiments
Conjugal transfer of resistance determinants was performed by both broth culture and on 0.45 mM nitrocellulose membranes (Millipore Corporation, Billerica, MA, USA) with E. coli J53 as recipient. After 24 h of incubation, mating mixtures were plated onto agar containing sodium azide (100 mg/L) supplemented with either trimethoprim (10 mg/L) or chloramphenicol (30 mg/L). Plasmid DNA was prepared from donors and transconjugants using a commercial kit (Plasmid Mini Kit, Qiagen GmbH, Hilden, Germany).
Genomic analysis
PFGE was performed with a CHEF DR III system (Bio-Rad, Hemel Hempstead, UK). DNA insert blocks were digested overnight with XbaI at 37 C.
PCR and sequencing
Total DNA for PCR was extracted by suspending bacteria in 5% Chelex-100 resin slurry (Bio-Rad) in injection grade water followed by boiling for 10 min. PCR was performed to detect the following: qnrA, 2 bla SHV , 10 TEM, CTX-M, VEB-1, PER-1, pACBL and class 1 integron cassette structures 3 0 -CS and 5 0 -CS conserved segments (integron variable region containing gene cassettes), intI1 integrase gene and sul1 conferring resistance to sulphonamides.
11 PCR products were detected by electrophoresis on 1.0% (w/v) agarose gels and extracted with a commercial kit (QIAquick gel extraction kit, Qiagen GmbH). Sequence determination of amplicons for both parents and transconjugants was performed on both strands using the respective PCR primers. Nucleotide sequence structures were compared with the following DDBJ/EMBL/GenBank accession numbers: qnrA, AY070235; SHV-1 X98100; aadA2, AJ517791, dfr16-aadA2, AY259085 and aacA4-aadA2, L06822.
Results
A total of 15 of the 47 test isolates (32%) were positive for the qnrA gene, and included single isolates of E. coli and C. freundii, 4 K. pneumoniae and 9 E. cloacae (Table 1) . Sequence analysis of the qnrA amplicons showed no variance from published data (AY070235). All 15 isolates originated from a variety of specialized high-dependency units within the RLUH. Genomic analysis by PFGE showed that two K. pneumoniae (QNR22 and 40) and three E. cloacae (QNR13, 16 and 44) were clonally but not temporally related.
Eleven of the fifteen qnrA-positive isolates expressed bla SHV-12 . E. coli-QNR3 demonstrated phenotypic ESBL production but was negative by PCR for b-lactamases TEM, SHV, CTX-M, VEB-1 and PER-1. Plasmid-encoded AmpC was not detected in the six non-Enterobacter spp. Three different In6-like class 1 integrons were found (Table 1) . Twelve isolates carried the aminoglycoside-3 0 -adenyltransferase gene aadA2 (pSAL-1-like), two isolates aacA4-aaA2 (In6-like), and a single isolate dfr16-aadA2 (In36-like). Plasmid transfer was achieved for five isolates but quinolone resistance was only detected in the E. coli J53 transconjugants (TCJs) crossed with K. pneumoniae QNR1 (E. coli TCJ-QNR1, plasmid 120 kb) and E. cloacae QNRQ3 (E. coli TCJ-QNRQ3, plasmid 160 kb). Both qnrA-positive plasmids carried bla SHV-12 and class 1 integrons with a pSAL-1-like gene cassette arrangement intl1-aadA2-qacED-sul1. Quinolone resistance in E. coli TCJ-QNR1 increased 6-fold for nalidixic acid (MIC 4.0-24 mg/L) and 12.5-fold for ciprofloxacin (MIC 0.008-0.1 mg/L) and in the E. coli TCJ-QNRQ3 12-fold for nalidixic acid (MIC 4.0-48 mg/L) and 24-fold for ciprofloxacin (MIC 0.008-0.19 mg/L). Resistance to amoxicillin, trimethoprim, gentamicin, kanamycin, cefotaxime, ceftazidime, aztreonam, sulphonamide and chloramphenicol was co-transferred on both plasmids. However, tetracycline resistance was only transferred to the E. coli TCJ-QNRQ3.
Conclusions
Since their introduction, quinolone resistance had been characterized by the absence of plasmid-mediated mechanisms. Unfortunately the detection in 1994 of the plasmid-mediated quinolone resistance gene qnrA in the United States and more recent sporadic worldwide reports illustrate the potential for their increased dissemination. To date the prevalence of studied bacteria carrying the qnrA gene appears low (<2.0% in 2200 combined test isolates [2] [3] [4] [5] [6] [7] ). An exception to this low level of detection was reported from Shanghai, where 6 (7.7%) of 78 ciprofloxacin-resistant E. coli gave positive hybridization signals with a qnrA gene probe. 3 But this is in a city where the frequency of quinolone resistance in clinical isolates of E. coli is unusually high, ranging from 53 to 57% between 1993 and 2001. 3 However, the majority of isolates examined in previous studies were collections of ciprofloxacinresistant Enterobacteriaceae. Therefore, as many of the reported cases of plasmid-mediated quinolone resistance are co-associated with pACBLs or ESBLs, and a close relationship between ESBL production and ciprofloxacin resistance in K. pneumoniae has been reported, 12 we have undertaken a study of bacteraemic isolates resistant to both ciprofloxacin and the third-generation cephalosporin cefotaxime.
By using PCR, a high prevalence of the plasmid-mediated quinolone resistance determinant qnrA was detected [15 of 47 (32%) ciprofloxacin-and cefotaxime-resistant Enterobacteriaceae isolated from bacteraemic patients at the RLUH]. The majority of isolates originated from high-dependency care units. Despite the international distribution of the qnrA determinant, our sequence analyses confirmed the maintained homogeneity of this gene.
PFGE has shown that most of our isolates were not clonal, yet 11 isolates, including K. pneumoniae, E. cloacae and C. freundii, were characterized by carriage of class 1 integrons with a similar gene cassette (aadA2) and expressing the ESBL bla . Other studies have demonstrated the association of ESBLs and pACBLs with the qnrA determinant, but this is the first report of association with SHV-12. Transferability of plasmid-mediated resistance was low, with only 2 of the 15 isolates producing quinolone-resistant transconjugants. Nalidixic acid resistance increased 6-to 12-fold and ciprofloxacin resistance increased 12-to 24-fold. The plasmids involved were large (120 and 160 kb), and carried class 1 integrons and multiple resistance determinants including bla SHV-12 .
Other studies have also shown that not all qnrA-positive isolates were able to transfer quinolone resistance. 5, 7 This combined carriage of the qnrA determinant with bla SHV-12 on similar class 1 integrons and its dissemination among differing Enterobacteriaceae in our institution may reflect a localized event. However, in the absence of other reports it may herald the unrecognized spread of integron-carrying bacteria in high-dependency units within UK hospitals.
